Pharmarise Holdings (2796) · FactChange of Listing Market to the Standard Market
Transfer to the Prime Market of the Tokyo Stock Exchange
First written in FY2022-Q3. 1 of 3 entries say "Achieved", first in FY2022. Latest entry: FY2024-Q2.
3entries
3years
0from disclosures
How it moved
Same theme, other companies
Change to the Standard Market after transitioning to the Tokyo Stock Exchange Prime MarketA theme 80 companies write about · 6 as a headwind · 5 as a tailwind
The whole theme swung hardest in 2022: 10 of 45 companies on the "Worse" side.
9 other companies' latest entry also says "Other".
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 80 companies compared. The sentences above are computed from all 80.Full recordFilings, disclosures and news, newest first
- FY2024-Q2Change of Listing Market to the Standard MarketAnnual report
「(Note) On 20 October 2023, the listing market segment for the Company's shares was changed from the Tokyo Stock Exchange Prime Market to the Tokyo Stock Exchange Standard Market.」
On 20 October 2023, the listing market segment was changed from the Tokyo Stock Exchange Prime Market to the Standard Market. - FY2022AchievedAnnual report
「April 2022 Transferred to the Prime Market following the Tokyo Stock Exchange's market segment restructuring.」
The transfer to the Prime Market was completed in April 2022 in connection with the Tokyo Stock Exchange's market segment restructuring. - FY2022-Q3First statedAnnual report
「Tokyo Stock Exchange First Section (as of the end of the second quarter accounting period) Prime Market (as of the date of filing)」
As of the end of the third quarter accounting period, the listed market was stated as the Tokyo Stock Exchange First Section, while it was the Prime Market as of the date of filing.